Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Novel circulating tumor cell-based blood test for the assessment of PD-L1 protein expression in treatment-naïve, newly diagnosed patients with non-small cell lung cancer.
Chen YL, Huang WC, Lin FM, Hsieh HB, Hsieh CH, Hsieh RK, Chen KW, Yen MH, Lee J, Su S, Marfatia T, Chang SE, Sundar P, Patterson B, Watson D, Mei R, Javey M. Chen YL, et al. Among authors: hsieh hb. Cancer Immunol Immunother. 2019 Jul;68(7):1087-1094. doi: 10.1007/s00262-019-02344-6. Epub 2019 May 14. Cancer Immunol Immunother. 2019. PMID: 31089757 Free PMC article.
ERCC1 expression in circulating tumor cells (CTCs) using a novel detection platform correlates with progression-free survival (PFS) in patients with metastatic non-small-cell lung cancer (NSCLC) receiving platinum chemotherapy.
Das M, Riess JW, Frankel P, Schwartz E, Bennis R, Hsieh HB, Liu X, Ly JC, Zhou L, Nieva JJ, Wakelee HA, Bruce RH. Das M, et al. Among authors: hsieh hb. Lung Cancer. 2012 Aug;77(2):421-6. doi: 10.1016/j.lungcan.2012.04.005. Epub 2012 May 1. Lung Cancer. 2012. PMID: 22555222
Multiple biomarker expression on circulating tumor cells in comparison to tumor tissues from primary and metastatic sites in patients with locally advanced/inflammatory, and stage IV breast cancer, using a novel detection technology.
Somlo G, Lau SK, Frankel P, Hsieh HB, Liu X, Yang L, Krivacic R, Bruce RH. Somlo G, et al. Among authors: hsieh hb. Breast Cancer Res Treat. 2011 Jul;128(1):155-63. doi: 10.1007/s10549-011-1508-0. Epub 2011 Apr 16. Breast Cancer Res Treat. 2011. PMID: 21499685 Free PMC article. Clinical Trial.
A rare-cell detector for cancer.
Krivacic RT, Ladanyi A, Curry DN, Hsieh HB, Kuhn P, Bergsrud DE, Kepros JF, Barbera T, Ho MY, Chen LB, Lerner RA, Bruce RH. Krivacic RT, et al. Among authors: hsieh hb. Proc Natl Acad Sci U S A. 2004 Jul 20;101(29):10501-4. doi: 10.1073/pnas.0404036101. Epub 2004 Jul 12. Proc Natl Acad Sci U S A. 2004. PMID: 15249663 Free PMC article.
High speed detection of circulating tumor cells.
Hsieh HB, Marrinucci D, Bethel K, Curry DN, Humphrey M, Krivacic RT, Kroener J, Kroener L, Ladanyi A, Lazarus N, Kuhn P, Bruce RH, Nieva J. Hsieh HB, et al. Biosens Bioelectron. 2006 Apr 15;21(10):1893-9. doi: 10.1016/j.bios.2005.12.024. Epub 2006 Feb 7. Biosens Bioelectron. 2006. PMID: 16464570
High-speed detection of occult tumor cells in peripheral blood.
Curry DN, Krivacic RT, Hsieh HB, Ladanyi A, Bergsrud DE, Ho MY, Chen LB, Kuhn P, Bruce RH. Curry DN, et al. Among authors: hsieh hb. Conf Proc IEEE Eng Med Biol Soc. 2004;2004:1267-70. doi: 10.1109/IEMBS.2004.1403401. Conf Proc IEEE Eng Med Biol Soc. 2004. PMID: 17271920
Monitoring signal transduction in cancer: from chips to fish.
Lersch RA, Fung J, Hsieh HB, Smida J, Weier HU. Lersch RA, et al. Among authors: hsieh hb. J Histochem Cytochem. 2001 Jul;49(7):925-6. doi: 10.1177/002215540104900715. J Histochem Cytochem. 2001. PMID: 11410619
13 results